1. Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?. (3rd September 2018) Authors: Torrente-Segarra, V; Bergstra, SA; Solomon-Escoto, K; Da Silva, JAP; Veale, DJ; Al-Emadi, S; Huizinga, TWJ Journal: Scandinavian journal of rheumatology Issue: Volume 47:Number 5(2018) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial. (4th July 2019) Authors: Hartman, L; Bos, R; Buttgereit, F; Güler-Yuksel, M; Ionescu, R; Kok, MR; Lems, WF; Micaelo, M; Opris-Belinski, D; Pusztai, A; Santos, EJF; Da Silva, JAP; Szekanecz, Z; Zeiner, K; Zhang, D; Boers, M Journal: Scandinavian journal of rheumatology Issue: Volume 48:Number 4(2019) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗